Redirecting gene editing vectors away from the liver whilst maintaining effective dosing remains one of the field’s most pressing delivery challenges. Join this workshop to explore real-world applications of reducing LNP and AAV liver tropism, enhancing tissue-specific targeting and investigating exosomal delivery approaches, giving you practical strategies to improve both safety and therapeutic efficacy.

Workshop highlights:

• Exploring real-world approaches to reducing LNP and AAV liver tropism, equipping you with strategies to improve the safety profile of your therapeutics
• Examining methods for enhancing tissue-specific targeting of delivery vectors, enabling you to direct therapies more precisely to the right disease area
• Investigating exosomal delivery as an emerging alternative to viral and lipid vectors, giving you a broader toolkit for extrahepatic genome editing applications
• Balancing safety and effective dosing in extrahepatic delivery design, helping you develop therapeutics that meet regulatory expectations without compromising efficacy